Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Valley Fever Global Market Report 2025
Request Sample Buy Now
Global Valley Fever Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : April 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Valley Fever Global Market Report 2025

By Types Of Treatment (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment), By Site Of Infection ( Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection), By End-Users (Human, Cattle, Sheep And Goats, Camel, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Valley Fever Market Overview

• Valley Fever market size has reached to $0.99 billion in 2024

• Expected to grow to $1.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%

• Growth Driver: Increasing Exposure To Fungus Spores Driving Infection Rates Due To Environmental And Human Activity Changes

• Market Trend: Innovative Vaccine Development Advancing Protection Against Fungal Infections

• North America was the largest region in 2024.

What Is Covered Under Valley Fever Market?

Valley fever, also called coccidioidomycosis, is a fungal infection that primarily affects the lungs and can cause symptoms such as cough, fever, fatigue, and chest pain, with some cases resulting in severe complications. It is caused by inhaling airborne spores of the coccidioides fungi, which are commonly present in dry, dusty soil and can become airborne when the soil is disturbed.

The main treatment types of valley fever are fluconazole, itraconazole, voriconazole, posaconazole, others. Fluconazole is an antifungal medication commonly used to treat fungal infections by inhibiting the growth of fungi. The various site of infection include skin, lungs, Liver, bones, heart, brain, membranes that surround the brain and spinal cord, others. These are used by various end-users such as human, cattle, sheep and goats, camel, others.

Valley Fever Market Size and growth rate 2025 to 2029: Graph

What Is The Valley Fever Market Size 2025 And Growth Rate?

The valley fever market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing climate change effects driving fungal spread, increasing research funding for Valley Fever treatments, rising investments in healthcare, rising demand for specialized diagnostic laboratories, and rising incidence of Valley Fever in non-endemic regions.

What Is The Valley Fever Market Growth Forecast?

The valley fever market size is expected to see strong growth in the next few years. It will grow to $1.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing adoption of telemedicine, rise in research on antifungal resistance, rise in funding for vaccine development, rise in population movement across high-risk areas, and increasing availability of antifungal treatments. Major trends in the forecast period include technological innovations, antifungal drug demand, vaccine development, telemedicine, and cross-border collaboration.

The forecast of 5.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to rapid antigen tests and antifungal drugs imported from Mexico and India, potentially worsening diagnostic delays and increasing infectious disease care burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Valley Fever Market Segmented?

1) By Types Of Treatment: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment

2) By Site Of Infection: Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection

3) By End-Users: Human, Cattle, Sheep And Goats, Camel, Other End-Users

Subsegmentss:

1) By Fluconazole Type: Oral Fluconazole, Intravenous Fluconazole

2) By Itraconazole Type: Capsule Itraconazole, Oral Solution Itraconazole

3) By Voriconazole Type: Oral Voriconazole, Intravenous Voriconazole

4) By Posaconazole Type: Oral Suspension Posaconazole, Delayed-Release Tablets Posaconazole, Intravenous Posaconazole

5) By Other Treatment Types: Combination Therapy, Adjunctive Therapy

What Is Driving The Valley Fever Market? Increasing Exposure To Fungus Spores Driving Infection Rates Due To Environmental And Human Activity Changes

The rising exposure to fungus spores is expected to propel the valley fever market going forward. Fungus spores are microscopic reproductive units produced by fungi that can spread through air, water, or surfaces, enabling the fungus to grow and reproduce in new environments. The exposure to fungus spores is increasing due to deforestation and changing weather patterns, which disturb soil and promote spore release, resulting to a higher risk of infections such as valley fever, especially in arid regions where the coccidioides fungus thrives. Valley fever treatment helps patients exposed to fungal spores by reducing symptoms, preventing complications, and controlling fungal growth, ultimately improving recovery and quality of life. For instance, in September 2024, according to the International Society for Infectious Diseases, a US-based non-profit organization, each year, invasive fungal infections impact about 6.5 million individuals, resulting in nearly 3.8 million fatalities, of which approximately 2.5 million are directly attributed to these infections. Therefore, the rising exposure to fungus spores is driving the growth of the valley fever industry.

What Is Driving The Valley Fever Market? Expansion Of Healthcare Facilities Driving The Growth Of The Market Due To Advancements In Medical Technology

The rising healthcare facilities is expected to propel the growth of the valley fever market going forward. Healthcare facilities refer to the essential physical facilities, systems, and resources needed to provide effective healthcare services. Expanding healthcare facilities is due to advancements in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics require upgraded facilities, specialized equipment, and enhanced healthcare delivery systems to improve patient outcomes and efficiency. Healthcare facilities support valley fever by providing early diagnosis, antifungal treatments, patient education, and ongoing care to manage symptoms and prevent complications. For instance, according to the American Hospital Association, a US-based non-profit organization, the United States had a total of 6,120 hospitals in 2024, marking an increase from 6,093 hospitals in 2022. Therefore, the expanding healthcare infrastructure is driving the growth of the valley fever industry.

Who Are The Major Players In The Global Valley Fever Market?

Major companies operating in the valley fever market are Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden Healthcare, Kabir Lifesciences

What Are The Key Trends Of The Global Valley Fever Market? Innovative Vaccine Development Advancing Protection Against Fungal Infections

Major companies operating in the valley fever market are focusing on developing innovative vaccines for valley fever to address the rising threat of fungal infections. Valley fever vaccines aim to protect people by leveraging advanced science and manufacturing techniques, enhancing public health and safety. For instance, in August 2024, Anivive Lifesciences Inc., a US-based pet pharmaceutical company, received a contract worth up to $33 million from the National Institute of Allergy and Infectious Diseases (NIAID), a US-based government agency to develop a human Valley Fever vaccine. The funding will support additional manufacturing, formulation, extensive safety testing, and a Phase 1 clinical trial, aiming to deliver the first vaccine to prevent a serious systemic fungal infection.

Need data on a specific region in this market?
Request Customisation

What Is The Regional Outlook For The Global Valley Fever Market?

North America was the largest region in the valley fever market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Valley Fever Market?

The valley fever market consists of sales of antifungal medications and steroids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Valley Fever Industry?

The valley fever market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the valley fever industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Valley Fever Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.05 billion
Revenue Forecast In 2034 $1.28 billion
Growth Rate CAGR of 5.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The valley fever market covered in this report is segmented –
1) By Types Of Treatment: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment
2) By Site Of Infection: Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection
3) By End-Users: Human, Cattle, Sheep And Goats, Camel, Other End-Users Subsegmentss:
1) By Fluconazole Type: Oral Fluconazole, Intravenous Fluconazole
2) By Itraconazole Type: Capsule Itraconazole, Oral Solution Itraconazole
3) By Voriconazole Type: Oral Voriconazole, Intravenous Voriconazole
4) By Posaconazole Type: Oral Suspension Posaconazole, Delayed-Release Tablets Posaconazole, Intravenous Posaconazole
5) By Other Treatment Types: Combination Therapy, Adjunctive Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden Healthcare, Kabir Lifesciences
Customization Scope Request for Sample
Pricing And Purchase Options Explore Purchase Options
Market Size Value In 2025 $1.05 billion
Revenue Forecast In 2034 $1.28 billion
Growth Rate CAGR of 5.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The valley fever market covered in this report is segmented –
1) By Types Of Treatment: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment
2) By Site Of Infection: Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection
3) By End-Users: Human, Cattle, Sheep And Goats, Camel, Other End-Users Subsegmentss:
1) By Fluconazole Type: Oral Fluconazole, Intravenous Fluconazole
2) By Itraconazole Type: Capsule Itraconazole, Oral Solution Itraconazole
3) By Voriconazole Type: Oral Voriconazole, Intravenous Voriconazole
4) By Posaconazole Type: Oral Suspension Posaconazole, Delayed-Release Tablets Posaconazole, Intravenous Posaconazole
5) By Other Treatment Types: Combination Therapy, Adjunctive Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden Healthcare, Kabir Lifesciences
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Valley Fever Market Characteristics

3. Valley Fever Market Trends And Strategies

4. Valley Fever Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Valley Fever Growth Analysis And Strategic Analysis Framework

5.1. Global Valley Fever PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Valley Fever Market Growth Rate Analysis

5.4. Global Valley Fever Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Valley Fever Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Valley Fever Total Addressable Market (TAM)

6. Valley Fever Market Segmentation

6.1. Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fluconazole

Itraconazole

Voriconazole

Posaconazole

Others Types Of Treatment

6.2. Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Skin

Lungs

Liver

Bones

Heart

Brain

Membranes That Surround The Brain And Spinal Cord

Other Sites Of Infection

6.3. Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human

Cattle

Sheep And Goats

Camel

Other End-Users

6.4. Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Fluconazole

Intravenous Fluconazole

6.5. Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Capsule Itraconazole

Oral Solution Itraconazole

6.6. Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Voriconazole

Intravenous Voriconazole

6.7. Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Suspension Posaconazole

Delayed-Release Tablets Posaconazole

Intravenous Posaconazole

6.8. Global Valley Fever Market, Sub-Segmentation Of Others Types Of Treatment, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Therapy

Adjunctive Therapy

7. Valley Fever Market Regional And Country Analysis

7.1. Global Valley Fever Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Valley Fever Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Valley Fever Market

8.1. Asia-Pacific Valley Fever Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Valley Fever Market

9.1. China Valley Fever Market Overview

9.2. China Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Valley Fever Market

10.1. India Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Valley Fever Market

11.1. Japan Valley Fever Market Overview

11.2. Japan Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Valley Fever Market

12.1. Australia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Valley Fever Market

13.1. Indonesia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Valley Fever Market

14.1. South Korea Valley Fever Market Overview

14.2. South Korea Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Valley Fever Market

15.1. Western Europe Valley Fever Market Overview

15.2. Western Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Valley Fever Market

16.1. UK Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Valley Fever Market

17.1. Germany Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Valley Fever Market

18.1. France Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Valley Fever Market

19.1. Italy Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Valley Fever Market

20.1. Spain Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Valley Fever Market

21.1. Eastern Europe Valley Fever Market Overview

21.2. Eastern Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Valley Fever Market

22.1. Russia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Valley Fever Market

23.1. North America Valley Fever Market Overview

23.2. North America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Valley Fever Market

24.1. USA Valley Fever Market Overview

24.2. USA Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Valley Fever Market

25.1. Canada Valley Fever Market Overview

25.2. Canada Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Valley Fever Market

26.1. South America Valley Fever Market Overview

26.2. South America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Valley Fever Market

27.1. Brazil Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Valley Fever Market

28.1. Middle East Valley Fever Market Overview

28.2. Middle East Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Valley Fever Market

29.1. Africa Valley Fever Market Overview

29.2. Africa Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Valley Fever Market Competitive Landscape And Company Profiles

30.1. Valley Fever Market Competitive Landscape

30.2. Valley Fever Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Horster Life Science Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Mankind Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Valley Fever Market Other Major And Innovative Companies

31.1. Atom Pharma

31.2. Ravoos Laboratories

31.3. Casca Remedies

31.4. Hema Pharmaceuticals

31.5. Globela Pharma

31.6. Spansules Pharmatech

31.7. Sanes Pharmaceuticals

31.8. CDH Chemicals

31.9. Sainor Laboratories

31.10. Maithili Life Sciences

31.11. Stratechem (I) Pvt. Ltd.

31.12. Shantam Pharma

31.13. Cerata Pharmaceuticals

31.14. Aden Healthcare

31.15. Kabir Lifesciences

32. Global Valley Fever Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Valley Fever Market

34. Recent Developments In The Valley Fever Market

35. Valley Fever Market High Potential Countries, Segments and Strategies

35.1 Valley Fever Market In 2029 - Countries Offering Most New Opportunities

35.2 Valley Fever Market In 2029 - Segments Offering Most New Opportunities

35.3 Valley Fever Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Valley Fever Market, Sub-Segmentation Of Others Types Of Treatment, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Valley Fever Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Valley Fever Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: Fresenius Kabi Financial Performance
  • Table 81: Dr. Reddy's Laboratories Financial Performance
  • Table 82: Horster Life Science Financial Performance
  • Table 83: Mankind Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Valley Fever Market, Sub-Segmentation Of Others Types Of Treatment, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Valley Fever Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Valley Fever Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: Fresenius Kabi Financial Performance
  • Figure 81: Dr. Reddy's Laboratories Financial Performance
  • Figure 82: Horster Life Science Financial Performance
  • Figure 83: Mankind Pharma Financial Performance

Strategic Growth Drivers Shaping the CRISPR And Cas Gene Market Outlook 2025- 2034:Personalized Therapy Driving Surge In CRISPR And Cas Gene Market Growth

Read More About Strategic Growth Drivers Shaping the CRISPR And Cas Gene Market Outlook 2025- 2034:Personalized Therapy Driving Surge In CRISPR And Cas Gene Market Growth

Emerging Growth Drivers in the Crohn's Disease (CD) Treatment Market Landscape: Increasing Prevalence Of Inflammatory Bowel Diseases Fuels Growth In The Crohn’S Disease Treatment Market

Read More About Emerging Growth Drivers in the Crohn's Disease (CD) Treatment Market Landscape: Increasing Prevalence Of Inflammatory Bowel Diseases Fuels Growth In The Crohn’S Disease Treatment Market

Cryochambers Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Cryochambers Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Cryotherapy Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Cryotherapy Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Musical Instruments Market 2023 – By Type (Stringed, Brass And Woodwind, Percussion, Keyboard), By Distribution Channel (Supermarkets\ Hypermarkets, Specialty Stores, Online Sales Channel), By Application (Commercial Eve...

View Report

Pharmaceutical Excipients Market 2023 – By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants...

View Report

Bakery Contract Manufacturing Global Market Report 2025 – By Product (Specialty And Nutritional Bakery Products, Traditional Bakery Products), By Service (Manufacturing, Packaging, Custom Formulation And R&D), By Applica...

View Report

Knee Implants Global Market Report 2025 – By Product (Total Knee Replacement, Partial Knee Replacement, Revision Knee Replacement), By Component Type (Fixed-Bearing Implants, Mobile-Bearing Implants), By Material (Stainl...

View Report

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2025 – By Type (Capping Agents, Nucleotides, Plasmid DNA, Other Types), By Applications (Therapeutics Production, Vaccine Production, Other A...

View Report

Automated Machine Learning (AutoML) Global Market Report 2025 – By Offering (Solutions, Services), By Deployment (Cloud, On-Premises), By Enterprise (Small And Medium Enterprise, Large Enterprise), By Application (Data P...

View Report

Retort Machine Global Market Report 2025 – By Process (Batch Sterilization, Continuous Sterilization), By Type (Saturated Steam, Water Immersion, Water Spray, Forced Steam Or Air), By End User (Food And Beverage Industry...

View Report

Viral Vectors And Plasmid DNA Global Market Report 2025 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, V...

View Report

Frequently Asked Questions

Valley fever, also called coccidioidomycosis, is a fungal infection that primarily affects the lungs and can cause symptoms such as cough, fever, fatigue, and chest pain, with some cases resulting in severe complications. It is caused by inhaling airborne spores of the coccidioides fungi, which are commonly present in dry, dusty soil and can become airborne when the soil is disturbed. For further insights on this market, request a sample here

The market major growth driver - Increasing Exposure To Fungus Spores Driving Infection Rates Due To Environmental And Human Activity Changes. For further insights on this market, request a sample here

The valley fever market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing climate change effects driving fungal spread, increasing research funding for Valley Fever treatments, rising investments in healthcare, rising demand for specialized diagnostic laboratories, and rising incidence of Valley Fever in non-endemic regions. The valley fever market size is expected to see strong growth in the next few years. It will grow to " $1.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing adoption of telemedicine, rise in research on antifungal resistance, rise in funding for vaccine development, rise in population movement across high-risk areas, and increasing availability of antifungal treatments. Major trends in the forecast period include technological innovations, antifungal drug demand, vaccine development, telemedicine, and cross-border collaboration. For further insights on this market, request a sample here

The valley fevermarket covered in this report is segmented –
1) By Types Of Treatment: Fluconazole; Itraconazole; Voriconazole; Posaconazole; Others Types Of Treatment
2) By Site Of Infection: Skin; Lungs; Liver; Bones; Heart; Brain; Membranes That Surround The Brain And Spinal Cord; Other Sites Of Infection
3) By End-Users: Human; Cattle; Sheep And Goats; Camel; Other End-Users Subsegments:
1) By Fluconazole Type: Oral Fluconazole; Intravenous Fluconazole
2) By Itraconazole Type: Capsule Itraconazole; Oral Solution Itraconazole
3) By Voriconazole Type: Oral Voriconazole; Intravenous Voriconazole
4) By Posaconazole Type: Oral Suspension Posaconazole; Delayed-Release Tablets Posaconazole; Intravenous Posaconazole
5) By Other Treatment Types: Combination Therapy; Adjunctive Therapy For further insights on this market, request a sample here

North America was the largest region in the valley fever market in 2024. The regions covered in the valley fever market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the valley fever market are Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden Healthcare, Kabir Lifesciences . For further insights on this market, request a sample here.

Major trends in this market include Innovative Vaccine Development Advancing Protection Against Fungal Infections. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Valley Fever Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top